Before we begin a busy Monday, we’re remembering Frederick Frank, a “founding father” of biotech investment, who passed away Saturday. Ahead of the UN General Assembly, we also look at an unprecedented editorial on the health impact of climate change as well as NIH programs to advance innovation…

A busy end to the week as a group of small biotech leaders and investors explain why H.R. 3 would halt investment in R&D—and offer alternative strategies to help patients get the drugs they need. Plus, the White House announced an administration-wide initiative to increase the production of…

A busy day with alarming new COVID data and how we can avoid a “twindemic” during flu season, plus what needs to happen at the UN Food Systems Summit. We have details on both, plus what’s happening in Washington and a lot of news links. (827 words, 4 minutes, 8 seconds)

Everyone’s back to work in D.C.—including Congress. We caught up with BIO’s Federal Government Relations team to find out what they’re monitoring as we head into fall. (1164 words, 5 minutes, 49 seconds)

It’s the Friday before Labor Day—but we have an important exclusive on human capital mobility during COVID-19 and the detrimental impact on the U.S. biotech sector. Also, don’t miss our webinar (on September 14) on how we can improve diversity in biotech by leveraging NIH’s SBIR and STTR programs. …

The WTO returns to work in Geneva on Monday—listen to our new bonus podcast episode for insight into how the next few weeks and months might go. We also explain why plant pandemics have met their match, thanks to CRISPR. (590 words, 2 minutes, 57 seconds)